companydata.dkcompanydata.dk

EXTRUDAN-SURGERY ApS: Financial statements 2023

CVR: 18655039

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

EXTRUDAN-SURGERY ApS (CVR 18655039) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 57,797 and a net result of DKK 66,881 compared with DKK -5,652 the year before. That is an increase of 1,805.6% compared with the year before. Equity in the 2023 report amounted to DKK 594,178. The solvency ratio was 92%.

Gross Profit
DKK 57,797
Profit/Loss
DKK 66,881
Equity
DKK 594,178
Total Assets
DKK 645,762

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-58 t.67 t.594 t.-
2022-3 t.-6 t.527 t.-
2021--12 t.-6 t.533 t.-
2020-51 t.27 t.539 t.-
2019-64 t.57 t.512 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

EXTRUDAN-SURGERY ApS: The 2022 annual report is outApr 21, 2023

EXTRUDAN-SURGERY ApS has published its annual report for 2022. Gross profit came to DKK 3,033, and the net result was DKK -5,652.

About EXTRUDAN-SURGERY ApS

EXTRUDAN-SURGERY ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 1995. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of John-Eric Pedersen. The company is owned by John-Eric Pedersen and Joanna Pukaczewska-Pedersen. The company has 1 employee (2000). In 2025, the company reported a gross profit of DKK 64,967 and a net result of DKK 54,142 compared with DKK 68,603 the year before. Equity in the 2025 report amounted to DKK 716,923.

Source: annual report 2025, Danish Business Authority